The global sore throat lozenges market is projected to be valued at USD 4.4 billion in 2024 and is expected to grow at a CAGR of 5.6%, reaching an estimated value of approximately USD 7.5 billion by ...
The global cold, cough, and sore throat remedy market is poised for steady growth, with a projected CAGR of 3.40% from 2024 to 2034. The market is estimated to be valued at US$ 42,618.7 million in ...
Advent International and Apollo Global Management Inc. are among buyout firms studying a potential acquisition of Reckitt Benckiser Group Plc’s homecare assets, according to people familiar with the ...
India's J B Chemicals & Pharmaceuticals reported a rise in second-quarter profit on Wednesday, helped by higher domestic demand for its gastrointestinal and cardiovascular drugs.